Founded in 1990, Paragon has a long tradition of accelerating biopharmaceutical development. Working as an outsourcing partner, and with along-standing tradition of quality and service, Paragon expands the capabilities of pharmaceutical companies, biotechnology companies and academic laboratories involved in identifying, developing and producing monoclonal antibodies, therapeutic proteins, disease biomarkers, vaccines and reagents for diagnostics. Highly-flexible and responsive, we work in partnership with our clients to ensure efficient and cost-effective preclinical target validation services, process development and scale-up production of biopharmaceuticals for research purposes or Phase I/II clinical trials. Paragon’s mission is to forge long-lasting partnerships and solid working relationships with ourclients. We are committed to honoring our delivery schedules and we strive to increase the return on investment for our clients. Paragon is currently embarking upon additional expansion which will double current preclinical andGMP manufacturing capacity and will bring Paragon’s total footprint to approximately 52,000 square feet. As part of the new space, Paragon will have 500L capacity for both mammalian and microbial GMP manufacturing projects, as well as fill and finish capabilities.
Paragon has built its service offering around the client’s need to validate a biopharmaceutical product and to ultimately produce batch sizes of material suitable for research purposes or Phase I/II clinicaltrials. By maintaining our focus on this market, Paragon offers cost-effective services to clients who outsource. Paragon’s team approaches each project with the understanding that every client’s research and manufacturing goals are unique. Our clients benefit from direct interaction with those responsible for the day-to-day management of their projects – knowledgeable and professional individuals empowered to make decisions to move your project forward. Strict confidentiality, periodic updates, clearly-presented information, effective project management, and timely delivery are hallmarks of our service.
Paragon understands the need to get a product to market quickly and economically. We work hard to gain insight into the potential product in development and to define appropriate methods to achieve project goals. Paragon’s multidisciplinary team of scientists have extensive experience in applied research, process engineering and biopharmaceutical development. Through work with our clients, the Paragon team is actively involved in the development of therapeutic proteins, vaccine candidates, monoclonal antibodies, and diagnostics including disease biomarkers.